Officials with the Indianapolis Public Schools recently announced that the district will receive more than $10 million from ...

Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...

Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

As part of its long-term investment in women’s sports, Eli Lilly will be present at the WNBA All-Star Game through breast ...

Boone County faces a critical shortage of licensed childcare seats with more than 600 children without access to care, a study has revealed. In early 2024, a much-needed study was conducted through ...

The Eli Lilly and Company Foundation awarded a multi-year grant of up to $5.5 million to the Indianapolis Public Schools (IPS ...

Dallas initiatives address food insecurity, education, arts funding, childcare, digital literacy, and civic engagement.

New Delhi [India], July 11 (ANI): Eli Lilly and Company (India), in collaboration with the Association of Physicians of India (API), on Friday announced the launch of API - Obesity Gurukul, a flagship ...

In the latest quarter, 7 analysts provided ratings for Eli Lilly (NYSE:LLY), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the ...

Demand for Eli Lilly’s LLY blockbuster GLP-1 medicines — Mounjaro (for type II diabetes) and Zepbound (for obesity) — remains strong. Despite being on the market for less than three years ...

Cantor Fitzgerald cut Eli Lilly’s FY2025 earnings forecast from $21.91 to $21.76 per share. Eli Lilly reported $3.34 per share in Q1 2025, missing analysts’ consensus estimate of $4.64. Despite this, ...